‘The case concerns a partnership founded during the COVID-19 pandemic to sell lateral flow tests (“LFTs”). Following the dissolution of the partnership, both partners continued selling COVID-19 LFTs through different entities, making substantial sums of money.’
Radcliffe Chambers, 28th July 2026
Source: radcliffechambers.com
